U.S. net product revenue in 2024 since launch in late September 2024 neffy 1 mg approved by U.S. FDA for children aged four ...

In addition to respiratory issues, allergies can affect the skin, leading to itching or rashes. Certain medications, such as ...

Anaphylaxis has been observed with PEMGARDA and the PEMGARDA Fact Sheet for Healthcare Providers includes a boxed warning for anaphylaxis. The most common adverse reactions included systemic ...

Q4 2024 Earnings Call Transcript March 20, 2025 ARS Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.52, ...

Of the remaining $71.5 million, $69.4 million was treated as a financing liability and $2.1 million was treated as a contract liability on the company's balance sheet due to Generally ... of allergic ...

Anaphylaxis has been observed with PEMGARDA and the PEMGARDA Fact Sheet for Healthcare Providers includes a boxed warning for anaphylaxis. The most common adverse reactions included systemic ...

Q4 2024 Earnings Call Transcript March 6, 2025 Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 Aquestive Therapeutics Earnings Conference Call. At this time, all ...

Australia’s booming $4 billion injectables market is driven by doctors issuing scripts via telehealth in consults that ...

In a class action loss against Bayer for harms caused by its Essure contraceptive device, some saw familiar failures of ...

Anaphylaxis has been observed with PEMGARDA and the PEMGARDA Fact Sheet for Healthcare Providers includes a boxed warning for anaphylaxis. The most common adverse reactions included systemic ...